Updated Question and Answer Document Regarding Nitrosamines Impurities for Market Authorization Holders of Human Pharmaceutical Products

Posted Date: 23-June-2020

Extension to provide confirmatory information on risk assessments for nitrosamine impurities

Please login to view this content.